Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:20 PM
Ignite Modification Date:
2025-12-24 @ 2:20 PM
NCT ID:
NCT00317395
Eligibility Criteria:
Inclusion Criteria:
* Ischemic discomfort at rest ≥ 10 minutes within 24 hours of randomization
* Electrocardiogram (ECG) criteria for non-ST elevation ACS or cardiac enzyme elevation (\> upper limit of normal \[ULN\])
* No ST elevation Myocardial Infarction (STEMI)
* Planned coronary angiography followed when indicated by a Percutaneous Coronary Intervention (PCI) on Day 1 to Day 3
Exclusion Criteria:
* Inability to undergo coronary angiography or PCI by Day 3
* Prior PCI within 30 days
* Acute STEMI
* Cardiogenic shock
* Anticoagulant treatment for \> 24 hours prior to randomization
* Prior treatment with fondaparinux since ACS onset
* Requirement for oral anticoagulant (OAC) prior to Day 30
* Creatinine clearance \< 30 ml/min
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00317395
Study Brief:
Protocol Section:
NCT00317395